Diagnosis of Localized, Screen-Detected, Prostate Cancer—Crisis or Opportunity?

In this article, the author comments on a study published within the issue which analyzed data on long-term outcomes for patients diagnosed with localized prostate cancer and possible implications for health care providers. The incorporation of prostate-specific antigen (PSA) and Gleason score data into the statistical models utilized by the researchers is noted. The author references a similar study conducted in the U.S. On final note, the author contends that the research study highlighted several health interventions that are often neglected.